Document Detail

Bis-sulfonic Acid Ionic Liquids for the Conversion of Fructose to 5-Hydroxymethyl-2-furfural.
MedLine Citation:
PMID:  23114616     Owner:  NLM     Status:  In-Data-Review    
Homogenous bis-sulfonic acid ionic liquids (1 mol equiv.) in DMSO (10 mol equiv.) at 100 °C efficiently mediated the conversion of D-fructose into 5-hydroxymethyl-2-furfural in 75% isolated yield, which was roughly a 10% increment compared to the case of the mono-sulfonic acid ionic liquids.
Sang Eun Sim; Sunjeong Kwon; Sangho Koo
Related Documents :
6631216 - Inactivation of rat liver hmg-coa reductase phosphatases by polycarboxylic acids.
17909886 - Characterization of phosphate-solubilizing fluorescent pseudomonads from the rhizospher...
8740176 - Phenotyping of esterase d and acid phosphatase by rapid isoelectric focusing on phastsy...
6306966 - Phosphoprotein phosphatase activity of human prostate acid phosphatase.
18417306 - Enhancing effect of labrafac lipophile wl 1349 on oral bioavailability of hydroxysafflo...
7494196 - Acid-base properties of terbutaline in terms of protonation macro- and microconstants.
Publication Detail:
Type:  Journal Article     Date:  2012-10-31
Journal Detail:
Title:  Molecules (Basel, Switzerland)     Volume:  17     ISSN:  1420-3049     ISO Abbreviation:  Molecules     Publication Date:  2012  
Date Detail:
Created Date:  2012-11-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100964009     Medline TA:  Molecules     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  12804-11     Citation Subset:  IM    
Department of Nano Science and Engineering, Myong Ji University, San 38-2, Nam-Dong, Yongin, Kyunggi-Do 449-728, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  DNA as a chiral scaffold for asymmetric synthesis.
Next Document:  Antimycobacterial Assessment of Salicylanilide Benzoates including Multidrug-Resistant Tuberculosis ...